{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:20:18Z","timestamp":1773112818127,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["15604475"],"award-info":[{"award-number":["15604475"]}]},{"name":"JSPS KAKENHI","award":["26460422"],"award-info":[{"award-number":["26460422"]}]},{"name":"JSPS KAKENHI","award":["15K08374"],"award-info":[{"award-number":["15K08374"]}]},{"name":"JSPS KAKENHI","award":["15551829"],"award-info":[{"award-number":["15551829"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12920-018-0359-5","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T23:51:05Z","timestamp":1525218665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dub\u00e9 syndrome: a case report"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-8179","authenticated-orcid":false,"given":"Mitsuko","family":"Furuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"issue":"12","key":"359_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, Nordenskjold M, Hansen TV, Solly J, Maher ER. Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 2009;10(12):1199\u2013206.","journal-title":"Lancet Oncol"},{"issue":"6","key":"359_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.2007.054304","volume":"45","author":"JR Toro","year":"2008","unstructured":"Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008;45(6):321\u201331.","journal-title":"J Med Genet"},{"issue":"2","key":"359_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002;2(2):157\u201364.","journal-title":"Cancer Cell"},{"issue":"42","key":"359_CR4","doi-asserted-by":"publisher","first-page":"15552","DOI":"10.1073\/pnas.0603781103","volume":"103","author":"M Baba","year":"2006","unstructured":"Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A. 2006;103(42):15552\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"359_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","volume":"415","author":"H Hasumi","year":"2008","unstructured":"Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M, Valera VA, Linehan WM, Schmidt LS. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene. 2008;415(1\u20132):60\u20137.","journal-title":"Gene"},{"issue":"40","key":"359_CR6","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/onc.2008.261","volume":"27","author":"Y Takagi","year":"2008","unstructured":"Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G, Zhang D, Abe M, Hagiwara Y, Takahashi K, et al. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL\/Fnip2) protein. Oncogene. 2008;27(40):5339\u201347.","journal-title":"Oncogene"},{"issue":"13","key":"359_CR7","doi-asserted-by":"publisher","first-page":"E1624","DOI":"10.1073\/pnas.1419502112","volume":"112","author":"H Hasumi","year":"2015","unstructured":"Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, et al. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Proc Natl Acad Sci U S A. 2015;112(13):E1624\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"359_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/stem.2293","volume":"34","author":"M Baba","year":"2016","unstructured":"Baba M, Toyama H, Sun L, Takubo K, Suh HC, Hasumi H, Nakamura-Ishizu A, Hasumi Y, Klarmann KD, Nakagata N, et al. Loss of Folliculin disrupts hematopoietic stem cell quiescence and homeostasis resulting in bone marrow failure. Stem Cells. 2016;34(4):1068\u201382.","journal-title":"Stem Cells"},{"issue":"5","key":"359_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol. 2010;7(5):277\u201385.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"359_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00428-005-0142-9","volume":"448","author":"M Kouchi","year":"2006","unstructured":"Kouchi M, Okimoto K, Matsumoto I, Tanaka K, Yasuba M, Hino O. Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt-Hogg-Dube syndrome. Virchows Arch. 2006;448(4):463\u201371.","journal-title":"Virchows Arch"},{"issue":"10","key":"359_CR11","doi-asserted-by":"publisher","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","volume":"3","author":"J Chen","year":"2008","unstructured":"Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, et al. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One. 2008;3(10):e3581.","journal-title":"PLoS One"},{"issue":"13","key":"359_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/onc.2009.14","volume":"28","author":"TR Hartman","year":"2009","unstructured":"Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, Henske EP. The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene. 2009;28(13):1594\u2013604.","journal-title":"Oncogene"},{"issue":"2","key":"359_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jnci\/djm288","volume":"100","author":"M Baba","year":"2008","unstructured":"Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, et al. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst. 2008;100(2):140\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"359_CR14","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/jnci\/djs418","volume":"104","author":"H Hasumi","year":"2012","unstructured":"Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, et al. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl Cancer Inst. 2012;104(22):1750\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"359_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.celrep.2014.03.025","volume":"7","author":"EA Goncharova","year":"2014","unstructured":"Goncharova EA, Goncharov DA, James ML, Atochina-Vasserman EN, Stepanova V, Hong SB, Li H, Gonzales L, Baba M, Linehan WM, et al. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Cell Rep. 2014;7(2):412\u201323.","journal-title":"Cell Rep"},{"issue":"21","key":"359_CR16","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1093\/hmg\/ddu286","volume":"23","author":"Y Hasumi","year":"2014","unstructured":"Hasumi Y, Baba M, Hasumi H, Huang Y, Lang M, Reindorf R, Oh HB, Sciarretta S, Nagashima K, Haines DC, et al. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hum Mol Genet. 2014;23(21):5706\u201319.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"359_CR17","doi-asserted-by":"publisher","first-page":"E1043","DOI":"10.1002\/humu.21130","volume":"31","author":"DH Lim","year":"2010","unstructured":"Lim DH, Rehal PK, Nahorski MS, Macdonald F, Claessens T, Van Geel M, Gijezen L, Gille JJ, Giraud S, Richard S, et al. A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene. Hum Mutat. 2010;31(1):E1043\u201351.","journal-title":"Hum Mutat"},{"issue":"10","key":"359_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","volume":"12","author":"LS Schmidt","year":"2015","unstructured":"Schmidt LS, Linehan WM. Molecular genetics and clinical features of Birt-Hogg-Dube syndrome. Nat Rev Urol. 2015;12(10):558\u201369.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"359_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/gcc.20872","volume":"50","author":"JN Benhammou","year":"2011","unstructured":"Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, et al. Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dube syndrome. Genes Chromosomes Cancer. 2011;50(6):466\u201377.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"359_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12931-016-0377-9","volume":"17","author":"X Zhang","year":"2016","unstructured":"Zhang X, Ma D, Zou W, Ding Y, Zhu C, Min H, Zhang B, Wang W, Chen B, Ye M, et al. A rapid NGS strategy for comprehensive molecular diagnosis of Birt-Hogg-Dube syndrome in patients with primary spontaneous pneumothorax. Respir Res. 2016;17(1):64.","journal-title":"Respir Res"},{"issue":"6","key":"359_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/430842","volume":"76","author":"LS Schmidt","year":"2005","unstructured":"Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet. 2005;76(6):1023\u201333.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"359_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cge.12807","volume":"90","author":"M Furuya","year":"2016","unstructured":"Furuya M, Yao M, Tanaka R, Nagashima Y, Kuroda N, Hasumi H, Baba M, Matsushima J, Nomura F, Nakatani Y. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dube syndrome. Clin Genet. 2016;90(5):403\u201312.","journal-title":"Clin Genet"},{"issue":"4","key":"359_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/jmg.2009.070565","volume":"47","author":"M Kunogi","year":"2010","unstructured":"Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S, Hino O, et al. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and\/or multiple lung cysts are the presenting feature. J Med Genet. 2010;47(4):281\u20137.","journal-title":"J Med Genet"},{"issue":"1","key":"359_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/pin.12028","volume":"63","author":"T Nishii","year":"2013","unstructured":"Nishii T, Tanabe M, Tanaka R, Matsuzawa T, Okudela K, Nozawa A, Nakatani Y, Furuya M. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dube syndrome. Pathol Int. 2013;63(1):45\u201355.","journal-title":"Pathol Int"},{"issue":"3","key":"359_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.jid.5700592","volume":"127","author":"MA van Steensel","year":"2007","unstructured":"van Steensel MA, Verstraeten VL, Frank J, Kelleners-Smeets NW, Poblete-Gutierrez P, Marcus-Soekarman D, Bladergroen RS, Steijlen PM, van Geel M. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dube patients. J Invest Dermatol. 2007;127(3):588\u201393.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"359_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/jhg.2016.118","volume":"62","author":"M Rossing","year":"2017","unstructured":"Rossing M, Albrechtsen A, Skytte AB, Jensen UB, Ousager LB, Gerdes AM, Nielsen FC, Hansen TV. Genetic screening of the FLCN gene identify six novel variants and a Danish founder mutation. J Hum Genet. 2017;62(2):151\u20137.","journal-title":"J Hum Genet"},{"issue":"10","key":"359_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1440-1827.2009.02434.x","volume":"59","author":"S Koga","year":"2009","unstructured":"Koga S, Furuya M, Takahashi Y, Tanaka R, Yamaguchi A, Yasufuku K, Hiroshima K, Kurihara M, Yoshino I, Aoki I, et al. Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int. 2009;59(10):720\u20138.","journal-title":"Pathol Int"},{"issue":"3","key":"359_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jclinpath-2012-201200","volume":"66","author":"M Furuya","year":"2013","unstructured":"Furuya M, Nakatani Y. Birt-Hogg-Dube syndrome: clinicopathological features of the lung. J Clin Pathol. 2013;66(3):178\u201386.","journal-title":"J Clin Pathol"},{"issue":"3","key":"359_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cas.12601","volume":"106","author":"M Furuya","year":"2015","unstructured":"Furuya M, Hong SB, Tanaka R, Kuroda N, Nagashima Y, Nagahama K, Suyama T, Yao M, Nakatani Y. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dube syndrome. Cancer Sci. 2015;106(3):315\u201323.","journal-title":"Cancer Sci"},{"key":"359_CR30","doi-asserted-by":"crossref","unstructured":"Hoshika Y, Takahashi F, Togo S, Hashimoto M, Nara T, Kobayashi T, Nurwidya F, Kataoka H, Kurihara M, Kobayashi E, et al. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dube syndrome. Physiol Rep. 2016;4(21):e13025.","DOI":"10.14814\/phy2.13025"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-018-0359-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:13:47Z","timestamp":1556738027000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0359-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0359-5","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"8 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies of germline and somatic mutations of FLCN and related molecular analyses were approved by the Institutional Review Boards of Yokohama City University (A161100001), and written informed consent for the studies was obtained from the patient. We confirmed that all processes were performed in accordance with the relevant guidelines including the CARE case report guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the patient\u2019s clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.Funding: This work was supported in part by JSPS KAKENHI grant number 26460422 (M.F.) 15\u00a0K08374 (Y.N.), 15,604,475 (M.B.), 15,551,829 (M.B.) and Project Mirai Cancer Research Grants (M.F.) in the writing of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"42"}}